Automated DBS Extraction Prior to Hilic/RP LC-MS/MS Target Screening of Drugs

Détails

Ressource 1Télécharger: REF.pdf (314.86 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_9184E25923F3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Automated DBS Extraction Prior to Hilic/RP LC-MS/MS Target Screening of Drugs
Périodique
Chromatographia
Auteur⸱e⸱s
Versace F., Deglon J., Lauer E., Mangin P., Staub C.
ISSN
0009-5893
ISSN-L
0009-5893
Statut éditorial
Publié
Date de publication
2013
Peer-reviewed
Oui
Volume
76
Numéro
19-20, SI
Pages
1281-1293
Langue
anglais
Résumé
This article describes a rapid LC-MS/MS target screening method based on an automated extraction of 5 mu L dried blood spots (DBS), two 5 min chromatographic runs on orthogonal phase columns (RP and Hilic) and a data dependent acquisition (DDA) of product ions spectra for the reliable identification of the detected compounds. The extraction step was performed in 2 min by using the LC autosampler itself in 96-well plates. This procedure was evaluated using 22 model compounds frequently encountered in forensic investigations, i.e., cocaine, benzodiazepines, amphetamines, opioids, antidepressants and antipsychotics. These investigations showed that even if the extraction step was reduced to a minimum, the extraction recoveries were satisfactory (median value of 40 %) and allowed for the detection of the model compounds in their therapeutic ranges, with the exception of morphine. Moreover, the use of two different chromatographic columns broadened the number of screening targets to those that behaved poorly under RP conditions, such as amphetamines or glucuronides, while keeping chromatographic gradients very short. This procedure was applied to 34 authentic post-mortem cases. It allowed the detection of 89 % of the compounds that were quantified in the routine procedures and the formal identification of 77 % of the compounds using their product ions spectra. These results were considered more than satisfactory compared to routine screening alone (GC-MS and LC-DAD, 55 % compound identification). The method described in this article is therefore a powerful approach for a fast, reliable and efficient target screening of drugs in forensic and clinical investigations.
Mots-clé
Biochemical Research Methods, Chemistry, Analytical
Web of science
Open Access
Oui
Création de la notice
09/08/2016 16:51
Dernière modification de la notice
14/02/2022 8:56
Données d'usage